SciELO - Scientific Electronic Library Online

 
vol.69 número1Estudio de caso: estimación de los costos de la quimioterapia aplicando el protocolo completo en niños con leucemia linfoblástica aguda o con linfoma de HodgkinPeso al nacer de los niños y niñas derechohabientes del Instituto Mexicano del Seguro Social índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Boletín médico del Hospital Infantil de México

versão impressa ISSN 1665-1146

Resumo

PARRA-TELLO, Teresita; HERNANDEZ-RAMOS, María Isabel; PEREZ-TAPIA, Sonia Mayra  e  LIMON-FLORES, Alberto Yairh. A retrospective study of the effect of mometasone furoate 0.1% in the nonsurgical treatment of phimosis and preputial adhesions in Mexican children. Bol. Med. Hosp. Infant. Mex. [online]. 2012, vol.69, n.1, pp.24-29. ISSN 1665-1146.

Background. In this study we evaluated the effect of mometasone furoate (0.1%) as a nonsurgical treatment of phimosis in Mexican children. Methods. We carried out a retrospective and descriptive study including 129 patients between 1 and 8 years old who were treated with the topical administration of 0.1% mometasone furoate on the prepuce and glans once daily for 4 weeks followed by sinechiotomy at the end of treatment. Results. After sinequiotomy, the foreskin was able to be fully retracted over the glans in 98% of the patients; however, in 20% of patients it returned to the original condition. Overall long-term efficacy was 81% (95% CI: 73-89). Conclusions. Topical administration of mometasone furoate (0.1%) was effective in the detachment of the foreskin of the prepuce from the glans, making it an effective, nonsurgical treatment for phimosis.

Palavras-chave : phimosis; synechiae; mometasone furoate; sinechiotomy; nonsurgical treatment; circumcision.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons